Cargando…
Harnessing Radiation Biology to Augment Immunotherapy for Glioblastoma
Glioblastoma is the most common adult primary brain tumor and carries a dismal prognosis. Radiation is a standard first-line therapy, typically deployed following maximal safe surgical debulking, when possible, in combination with cytotoxic chemotherapy. For other systemic cancers, standard of care...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395389/ https://www.ncbi.nlm.nih.gov/pubmed/30854331 http://dx.doi.org/10.3389/fonc.2018.00656 |